Documente Academic
Documente Profesional
Documente Cultură
HEALTHCARE
SECTOR:
Opportunities and Challenges
PGDM (RM)
K. J. Somaiya Institute of Management & Studies
Vidyanagar, Mumbai- 400077
Page |2
Group Members
1) Divya Kumar(21)
2) Ansu Grover(12)
3) Honey(28)
4) Nishant Chhabra(6)
5) Sushant Kumar Suman(46)
6) Alok Kumar (20)
Page |3
Index
Introduction
3. Medical Infrastructure-
a. Current state
c. Manpower Statistics
d. Medical Education
4. Policy Initiative
13. Biotechnology
20. Telemedicine
22. Insurance
28. Challenges
Introduction
Objective: - To analyze the business potential and study the major brands
in the health-care sector in India.
2006 2012
100%=$34.2b 100%=$78.6 bn
n
14% Infrastructure 14%
5% Medical Equipment 5%
1% Clinical Trials 1%
6% Medical Consumables 5%
Source: The Business World, Ernst & Young Survey; June 2007
3. Medical infrastructure
A. Current state
• Current Hospital beds per 1000 population stands at 1.11
C. Manpower Statistics
• Number of Doctors - 660,801
D. Medical Education
• 229 recognized medical colleges of which 106 were established through
the private route
4. Policy Initiative
National Health Policy-2002
• The National Health Policy 2002 focuses on the need for enhanced
funding and organisational restructuring of the national public health
initiatives in order to facilitate more equitable access to health facilities.
• Greater contribution from the Central Budget for the delivery of public
health services at the state level.
• Growing need for improved healthcare infrastructure in tier II & III cities
• Soukya in Bangalore
P a g e | 14
• Yoga
• Herbal Medicine
• Humour therapy
• Acupuncture
• Blood Banks
• Diagnostic Centres
• Dental Hospitals/Clinics
• Domestic health policy premiums have shown a 47% increase in the first
quarter of 2006.
13. Biotechnology
Indian companies are driven to innovative research and are
establishing their own niche areas: Reliance Life Sciences is planning to
launch genetically engineered skin; Avesthagen has won a US patent for
multiple use genetic modification technology; GlaxoSmithKline Biologicals
has plans to launch a number of vaccines like new-generation DTP,
rotavirus and cervical cancer for its global portfolio. Similarly, Xcyton, a
small biotech diagnostic kit-maker has made its presence felt in the global
and domestic diagnostics market. Several biotech medicines are due to
come off patent in the next few years, and pharmacy majors are looking
at India for contracting research and manufacturing of biologic generics.
India is becoming a talented and cost- competitive destination for
biotechnology research, product development, toxicity studies and clinical
P a g e | 19
• The Asian Heart Institute, Mumbai plans to invest US$ 7.32 million for
expansion activities and is actively exploring acquisition targets outside
Mumbai
Managed
Clinic Apollo clinics 50
Pharmacy Apollo pharmacies 415 Retail Pharmacy- Direct access
to
Patients, low capital
requirement for hospital
pharmacies, higher bargaining
power with pharmacy
companies.
Tele- Apollo Tele- Over Access to huge medical
Medicine medicines 60 network; helps expand reach
networking and achieve growth
foundation(ATNF)
Insurance (As a TPA) - Access to patients, medical
network, and claim processing
Outsourcin Apollo Health - Caters to health Information needs
g (BPO) Street of U.S. based Physician groups and
hospitals
• Has tied up with insurers like BUPA (UK), Vanbreda (Belgium) and
Mondial (France) to direct inflow of foreign patients to India
• Has tied up with Indian Oil Corporation (IOC) to set up its pharmacies at
the latter’s petrol stations.
Fortis Healthcare
• Has a chain of hospitals with an installed bed capacity of about 1,790
beds
• Has a joint venture with Real Estate player DLF to set up hospitals
across the country with an investment of about US$ 1.5 billion
P a g e | 21
• Owns a pharmacy chain by the name of Fortis Health world and plans to
open 250 outlets with an investment of US$ 195 million all over India
Wockhardt Hospitals
• 8 hospitals across India, of which 5 are owned
• Plan to invest over US$ 195 million in healthcare business in the next
five years.
Narayana Hrudayalaya
• First-of-its-kind cardiac care hospital in Bangalore, set up by the Asia
Heart Foundation (AHF)
P a g e | 22
Max Healthcare
• MHC operates 8 healthcare centres in the National Capital Region (NCR)
• Plans to raise US$ 85.36 - 97.56 million to expand its hospital chain
Columbia Asia
• First healthcare provider to enter through the FDI route
Global Hospitals
• The US$ 9.75 million facility functions from 2 locations in Hyderabad
• The quaternary healthcare centre with 500 bed facility is spread over 16
acres
• Planning a pan India chain of hospitals; has begun talks with leading
private hospitals in Delhi, Mumbai and Bangalore for possible acquisitions
and joint ventures
Foreign Players
P a g e | 24
• Parkway Group from Singapore, Emaar from the Middle East and
Prexeus Health Partners from the US have announced plans
• Hinduja Group and Limitless LLC, the realty arm of Dubai World, are
putting in about US$ 1.1 billion in their 51:49 JV to build hospitals and
medicare cities
– Private equity, acquisitions, FDI, FII, NRI investment, joint ventures, tie-
ups, Venture Capital, IPOs
– Parkway Group from Singapore, Emaar from the Middle East and Prexeus
Health Partners from the US have announced plans
20. Telemedicine
• Opportunities to integrate telemedicine into healthcare to increase
patient base, productivity, and enable cost effective delivery
– 1.27 doctors (all kinds) and 0.5 doctors (allopathic) per thousand
persons in India compared to world average of 1.5 (2006)
4.97 billion (Rs 22,396 Cr) by 2012 Currently over 65% of the medical
equipments are imported and thus is a key area for forging partnerships
across borders. Engineering excellence, cost-effective labour, increasing
emphasis on intellectual property rights and most importantly a fast
growing domestic market makes India an ideal manufacturing base.
• Potential to contribute US$ 1.2 - 2.4 billion additional revenue for up-
market tertiary hospitals by 2012, and will account for 3-5% of the total
healthcare delivery market
• Major hospital chains are now hiring hospital planning consultancy firms
for a better and faster scale up of their facilities
• Established firms provide services ranging from a one stop solution; new
and emerging players prefer to work on few specialised areas
• Hosmac, Mumbai
• Hospic, Mumbai
Indian market for medical textiles is worth US$ 500 million; global
market is worth US$ 8.2 billion. Growth in medical infrastructure will be
accompanied by demand for associated products and services. One such
important industry is medical textiles. India’s market for medical textiles
is growing at 10–12%, which shall almost double to a US$ 753 Million (Rs
3,388 Cr) industry by 2012 from the current US$ 405 Million (Rs 1822 Cr).
Clinical Trials
• Indian clinical trials market in 2006 was US$ 140 million and is growing
at a CAGR of 40 % for the last 3 years
• National Centre for Clinical Trials has been established at Tata Memorial
Hospital
• Medical Coding
• Medical Billing
- Patient Demographics
- Charge Entry
• Claims Processing
- Accounts Receivable
P a g e | 33
- Teleradiology
- Medical Transcription
– Since January 2000 up to 100 percent FDI allowed under automatic route
in hospitals in India
– FIIs and private equity funding permitted under FDI, with certain
conditions
– FIIs and private equity funds can individually purchase up to 10% and
collectively up to 24% of paid up share capital of company via open offers
or private placement or through stock exchange
– Development agencies
28. Challenges
External constraints
• Healthcare undergoing reform and internal problems in overseas
economies.
• Competing destinations
Domestic constraints
• Initial and post establishment related operational issues adversely affect
returns to investment in hospitals in India
• Land, equipment
– Depreciation of assets
THANK YOU